Optimal Cut-Off Values of the Positive Lymph Node Ratio and the Number of Removed Nodes for Patients Receiving Resection of Bronchopulmonary Carcinoids: A Propensity Score-Weighted Analysis of the SEER Database

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Aug 9

PMID 34367980

Citations 3

Authors

Qichen Chen

Mingxia Li

Pan Wang

Jinghua Chen

Hong Zhao

Jun Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Although lymph node dissection (LND) has been commonly used for patients with bronchopulmonary carcinoids (PCs), the prognostic values of the positive lymph node ratio (PLNR) and the number of removed nodes (NRN) remain unclear.

Methods: Patients with resected PCs were identified in the Surveillance, Epidemiology, and End Results (SEER) database (2010-2015). The optimal cut-off values of the PLNR and NRN were determined by X-tile. The inverse probability of treatment weighting (IPTW) method was used to reduce the selection bias. IPTW-adjusted Kaplan-Meier curves and Cox proportional hazards models were used to compare the overall survival (OS) and cancer-specific survival (CSS) of patients in different PLNR and NRN groups.

Results: The study included 1622 patients. The optimal cut-off values of the PLNR and NRN for survival were 13% and 13, respectively. In both Kaplan-Meier analysis and univariable Cox proportional hazards regression analysis before IPTW, a PLNR ≥13% was significantly associated with worse OS (HR = 3.364, P<0.001) and worse CSS (HR = 7.874, P<0.001). These findings were corroborated by the IPTW-adjusted Cox analysis OS (HR = 2.358, P = 0.0275) and CSS (HR = 8.190, P<0.001) results. An NRN ≥13 was not significantly associated with worse OS in either the Kaplan-Meier or Cox analysis before or after IPTW adjustment. In the Cox proportional hazards analysis before and after IPTW adjustment, an NRN ≥13 was significantly associated with worse CSS (non-IPTW: HR = 2.216, P=0.013; IPTW-adjusted: HR = 2.162, P=0.024).

Conclusion: A PLNR ≥13% could predict worse OS and CSS in patients with PCs and might be an important complement to the present PC staging system. Extensive LND with an NRN ≥13 might have no therapeutic value for OS and may even have an adverse influence on CSS. Its application should be considered on an individual basis.

Citing Articles

Lymphadenectomy and optimal excise lymph nodes count for early-stage primary fallopian tube cancer: a SEER-based study.

Liu Y, Huang F, Gu Q, Wang J, Wang Q, Wu Y BMC Womens Health. 2023; 23(1):681.

PMID: 38129825 PMC: 10740229. DOI: 10.1186/s12905-023-02833-y.

Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues.

Brascia D, Marulli G Curr Treat Options Oncol. 2022; 23(12):1645-1663.

PMID: 36269459 PMC: 9768012. DOI: 10.1007/s11864-022-01026-3.

Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study.

Liang L, Liu Z, Wang C, Xie S Front Oncol. 2022; 12:940839.

PMID: 36091171 PMC: 9452885. DOI: 10.3389/fonc.2022.940839.

References

Singh S, Bergsland E, Card C, Hope T, Kunz P, Laidley D . Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and.... J Thorac Oncol. 2020; 15(10):1577-1598. DOI: 10.1016/j.jtho.2020.06.021. View

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y . Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10):1335-1342. PMC: 5824320. DOI: 10.1001/jamaoncol.2017.0589. View

Marciello F, Mercier O, Ferolla P, Scoazec J, Filosso P, Chapelier A . Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter Study. Neuroendocrinology. 2017; 106(3):264-273. DOI: 10.1159/000480015. View

Yoon J, Sigel K, Martin J, Jordan R, Beasley M, Smith C . Evaluation of the Prognostic Significance of TNM Staging Guidelines in Lung Carcinoid Tumors. J Thorac Oncol. 2018; 14(2):184-192. DOI: 10.1016/j.jtho.2018.10.166. View

Kim M, Warner R, Ward S, Harpaz N, Roayaie S, Schwartz M . Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology. 2015; 101(1):58-65. PMC: 4403253. DOI: 10.1159/000371807. View

Li J, Lin Y, Wang Y, Lin H, Lin F, Zhuang Q . Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis. ESMO Open. 2020; 5(2). PMC: 7174016. DOI: 10.1136/esmoopen-2019-000632. View

Pathipati M, Yohannan T, Tian L, Hornbacker K, Benson J, Berry G . Examination of factors associated with lymph node metastases in lung carcinoids: Results from a single institution retrospective cohort study. Lung Cancer. 2021; 154:186-194. PMC: 8026717. DOI: 10.1016/j.lungcan.2021.01.017. View

Lim E, Yap Y, De Stavola B, Nicholson A, Goldstraw P . The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. J Thorac Cardiovasc Surg. 2005; 130(4):969-72. DOI: 10.1016/j.jtcvs.2005.05.041. View

Zhu J, Xue Z, Zhang S, Guo X, Zhai L, Shang S . Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis. Int J Surg. 2018; 57:76-83. DOI: 10.1016/j.ijsu.2018.08.002. View

10.

Zhu Z, Song Z, Jiao W, Mei W, Xu C, Huang Q . A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer. Transl Lung Cancer Res. 2021; 10(2):815-825. PMC: 7947406. DOI: 10.21037/tlcr-20-1024. View

11.

Darling G, Allen M, Decker P, Ballman K, Malthaner R, Inculet R . Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Chest. 2010; 139(5):1124-1129. PMC: 3087457. DOI: 10.1378/chest.10-0859. View

12.

George B, Seals S, Aban I . Survival analysis and regression models. J Nucl Cardiol. 2014; 21(4):686-94. PMC: 4111957. DOI: 10.1007/s12350-014-9908-2. View

13.

Chen X, Pang Z, Wang Y, Bie F, Zeng Y, Wang G . The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database. Lung Cancer. 2019; 139:94-102. DOI: 10.1016/j.lungcan.2019.11.006. View

14.

Zhang C, Li Y, Zhang Q, Biondi A, Fico V, Persiani R . The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer. Front Oncol. 2019; 8:628. PMC: 6305371. DOI: 10.3389/fonc.2018.00628. View

15.

Caplin M, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E . Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. 2015; 26(8):1604-20. DOI: 10.1093/annonc/mdv041. View

16.

Teng J, Abdygametova A, Du J, Ma B, Zhou R, Shyr Y . Bayesian Inference of Lymph Node Ratio Estimation and Survival Prognosis for Breast Cancer Patients. IEEE J Biomed Health Inform. 2019; 24(2):354-364. DOI: 10.1109/JBHI.2019.2943401. View

17.

Grondahl V, Binderup T, Langer S, Petersen R, Nielsen K, Kjaer A . Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence. Lung Cancer. 2019; 132:141-149. DOI: 10.1016/j.lungcan.2019.03.013. View

18.

Lim W, Ridge C, Nicholson A, Mirsadraee S . The 8 lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018; 8(7):709-718. PMC: 6127520. DOI: 10.21037/qims.2018.08.02. View

19.

Baudin E, Caplin M, Garcia-Carbonero R, Fazio N, Ferolla P, Filosso P . Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021; 32(4):439-451. DOI: 10.1016/j.annonc.2021.01.003. View

20.

Gaitanidis A, Patel D, Nilubol N, Tirosh A, Kebebew E . A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors. J Clin Endocrinol Metab. 2017; 103(1):187-195. PMC: 5761495. DOI: 10.1210/jc.2017-01791. View